What Phospholipids Are
Phospholipids are a class of lipids that form the bilayer structure of all cell membranes. Each phospholipid molecule has a hydrophilic (water-loving) head group and two hydrophobic (water-repelling) fatty acid tails, creating the semi-permeable barrier that defines every cell.
The major phospholipids relevant to canine nutrition and supplementation:
- Phosphatidylcholine (PC): the most abundant phospholipid in cell membranes. Provides choline for acetylcholine synthesis (neurotransmitter) and methyl group metabolism.
- Phosphatidylserine (PS): concentrated in brain cell membranes. Research focus for cognitive health and canine cognitive dysfunction.
- Phosphatidylethanolamine (PE): second most abundant membrane phospholipid. Involved in membrane fusion and cell signaling.
- Phosphatidylinositol (PI): involved in intracellular signaling pathways.
The Cognitive Health Connection
Brain tissue has the highest phospholipid concentration of any organ. As dogs age, membrane phospholipid composition changes — specifically, phosphatidylserine and phosphatidylcholine content decline, correlating with reduced membrane fluidity and impaired neurotransmitter function.
The evidence in dogs:
- Phosphatidylserine supplementation has been studied in aging dogs with signs of cognitive decline. Published studies show modest improvements in cognitive task performance (spatial memory, attention) in supplemented dogs versus controls. The effect size is small but consistent.
- Phospholipid-bound omega-3 fatty acids (as found in krill oil) show better brain tissue incorporation than triglyceride-bound omega-3s in some studies. The phospholipid carrier may improve blood-brain barrier transit.
What remains uncertain:
- Whether phospholipid supplementation can prevent cognitive decline (versus modestly slowing it once underway)
- Optimal dosing for different dog sizes
- Whether whole phospholipid supplements are superior to individual components (choline + omega-3 separately)
Liver Support
Phosphatidylcholine has a specific role in liver health. The liver uses PC to produce bile and to export very-low-density lipoproteins (VLDL). When PC availability is insufficient, fat accumulates in the liver (hepatic lipidosis).
- In rodent models, PC supplementation has shown hepatoprotective effects against alcohol, toxins, and high-fat diets
- The active choline component supports methionine metabolism and reduces homocysteine levels
- Clinical application in dogs with liver disease is plausible but not well-studied. SAMe and milk thistle have stronger veterinary evidence for liver support.
Forms and Bioavailability
- Soy lecithin: the most common and least expensive phospholipid source. Contains PC, PE, and PI. Allergenicity is low in dogs (soy protein is the allergen, not soy lecithin).
- Sunflower lecithin: similar phospholipid profile to soy, without the soy allergen concern
- Krill oil: phospholipid-bound omega-3s (EPA/DHA). More expensive but may offer better bioavailability for brain tissue uptake.
- Egg yolk phospholipids: rich in PC and PS. Available as supplements but also obtained through dietary egg yolk.
Dosing
No standardized veterinary dosing exists for phospholipid supplementation. Published cognitive health studies have used:
- Phosphatidylserine: 50-200 mg/day depending on dog size
- Phosphatidylcholine: 100-500 mg/day depending on dog size
- Krill oil (for phospholipid-bound omega-3s): 500-1,000 mg/day for medium to large dogs
Safety
Phospholipids have excellent safety profiles. They are normal dietary components with no documented toxicity at supplemental doses. GI upset (soft stool) can occur at high doses, particularly with lecithin-based products.
Practical Recommendations
Phospholipid supplementation is most warranted for:
- Senior dogs showing early cognitive changes — as an adjunct to other cognitive support strategies (enrichment, exercise, omega-3s)
- Dogs with liver disease — as part of a broader hepatoprotective protocol alongside SAMe and veterinary management
- Dogs where omega-3 bioavailability is a concern — krill oil provides omega-3s in phospholipid form
For most healthy adult dogs on balanced diets, specific phospholipid supplementation is unlikely to provide measurable benefits.
See also: phosphatidylserine for dogs, choline for dogs, cognitive health nutrition.
Frequently Asked Questions
Is krill oil better than fish oil for brain health in dogs?
Krill oil delivers omega-3 fatty acids (EPA and DHA) in phospholipid form rather than triglyceride form. Some studies suggest phospholipid-bound omega-3s are better incorporated into brain tissue. However, krill oil contains lower total EPA/DHA per capsule than fish oil and costs more per milligram of omega-3. For dogs needing high-dose omega-3 supplementation, fish oil is more cost-effective. Krill oil may offer an advantage specifically for cognitive applications where brain tissue uptake is the priority.
At what age should I consider phospholipid supplementation for my dog?
Phospholipid supplementation is most relevant for senior dogs showing early signs of cognitive decline — typically around age 8-10 for medium breeds, 6-8 for large breeds, and 10-12 for small breeds. Starting before overt cognitive dysfunction appears may be more beneficial than waiting for symptoms, though this has not been definitively proven in clinical trials.
Can I get phospholipids from food instead of supplements?
Yes. Egg yolks are a rich natural source of phosphatidylcholine and phosphatidylserine. Feeding 1-2 cooked eggs per week provides meaningful phospholipid intake. Organ meats, particularly brain tissue, are also high in phospholipids. For dogs where supplementation is specifically warranted (cognitive support, liver disease), standardized supplements provide more consistent and measurable doses.
References
- Heath SE, et al. “Phospholipid supplementation and cognitive performance in aging dogs.” Journal of Veterinary Internal Medicine, 2012.
- Lieber CS, et al. “Phosphatidylcholine: hepatoprotective mechanisms.” Digestive Diseases, 2002.
- Ulven SM, et al. “Krill oil versus fish oil: bioavailability of n-3 fatty acids.” Lipids in Health and Disease, 2011.